Evidence map›Paper›PMID 33299078›Full record

ArticleScientific reports2020

The polymicrogyria-associated GPR56 promoter preferentially drives gene expression in developing GABAergic neurons in common marmosets.

Ayako Y Murayama, Ken-Ichiro Kuwako, Junko Okahara, Byoung-Il Bae, Misako Okuno, Hiromi Mashiko, Tomomi Shimogori, Christopher A Walsh, Erika Sasaki, Hideyuki Okano

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ayako Y MurayamaDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan.
Ken-Ichiro KuwakoDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan.
Junko OkaharaLaboratory for Marmoset Neural Architecture, Center for Brain Science, RIKEN, Wako, Japan.
Byoung-Il BaeDivision of Genetics and Genomics, Manton Center for Orphan Disease Research, and Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.
Misako OkunoLaboratory for Marmoset Neural Architecture, Center for Brain Science, RIKEN, Wako, Japan.
Hiromi MashikoLaboratory for Molecular Mechanisms of Brain Development, Center for Brain Science, RIKEN, Wako, Japan.
Tomomi ShimogoriLaboratory for Molecular Mechanisms of Brain Development, Center for Brain Science, RIKEN, Wako, Japan.
Christopher A WalshDivision of Genetics and Genomics, Manton Center for Orphan Disease Research, and Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.
Erika SasakiLaboratory for Marmoset Neural Architecture, Center for Brain Science, RIKEN, Wako, Japan. esasaki@ciea.jp.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo, Japan. hidokano@keio.jp.
Keio University · JPRIKEN Center for Brain Science · JPCentral Institute for Experimental Animals · JPBroad Institute · USUniversity of Connecticut · US

Funding

HUMAN EPILEPSY GENETICS--NEURONAL MIGRATION DISORDERSR01NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 1997 to 2023
$9.5M
NINDS NIH HHS R01 NS035129
6 · The paper itself

Abstract

GPR56, a member of the adhesion G protein-coupled receptor family, is abundantly expressed in cells of the developing cerebral cortex, including neural progenitor cells and developing neurons. The human GPR56 gene has multiple presumptive promoters that drive the expression of the GPR56 protein in distinct patterns. Similar to coding mutations of the human GPR56 gene that may cause GPR56 dysfunction, a 15-bp homozygous deletion in the cis-regulatory element upstream of the noncoding exon 1 of GPR56 (e1m) leads to the cerebral cortex malformation and epilepsy. To clarify the expression profile of the e1m promoter-driven GPR56 in primate brain, we generated a transgenic marmoset line in which EGFP is expressed under the control of the human minimal e1m promoter. In contrast to the endogenous GPR56 protein, which is highly enriched in the ventricular zone of the cerebral cortex, EGFP is mostly expressed in developing neurons in the transgenic fetal brain. Furthermore, EGFP is predominantly expressed in GABAergic neurons, whereas the total GPR56 protein is evenly expressed in both GABAergic and glutamatergic neurons, suggesting the GABAergic neuron-preferential activity of the minimal e1m promoter. These results indicate a possible pathogenic role for GABAergic neuron in the cerebral cortex of patients with GPR56 mutations.

Indexed as

AnimalsAnimals, Genetically ModifiedBase SequenceBrainCallithrixCell MovementCerebral CortexGABAergic NeuronsGene ExpressionHomozygoteHumansMutationNeural Stem CellsPolymicrogyriaPromoter Regions, GeneticReceptors, G-Protein-CoupledADGRG1 protein, humanReceptors, G-Protein-Coupled

Identifiers

PMID33299078
PMCPMC7726139
OpenAlexW3111440967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.